Cargando…

Health system support among patients with ME/CFS in Switzerland

OBJECTIVES: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex chronic and debilitating multifactorial disease. Adequate patient care is challenged by poor knowledge among health care professionals and the historical misconception that the disease is psychological in nature. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Tschopp, Rea, König, Rahel S., Rejmer, Protazy, Paris, Daniel H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taibah University 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957780/
https://www.ncbi.nlm.nih.gov/pubmed/36852237
http://dx.doi.org/10.1016/j.jtumed.2022.12.019
_version_ 1784894905395445760
author Tschopp, Rea
König, Rahel S.
Rejmer, Protazy
Paris, Daniel H.
author_facet Tschopp, Rea
König, Rahel S.
Rejmer, Protazy
Paris, Daniel H.
author_sort Tschopp, Rea
collection PubMed
description OBJECTIVES: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex chronic and debilitating multifactorial disease. Adequate patient care is challenged by poor knowledge among health care professionals and the historical misconception that the disease is psychological in nature. This study assessed the health-related challenges faced by patients with ME/CFS in Switzerland and examined whether they receive adequate health care. METHODS: Quantitative and qualitative data were collected through a self-administered questionnaire between June and September of 2021, among 169 patients with ME/CFS in Switzerland. RESULTS: The mean age at diagnosis was 38.8 years. Only one-third of ME/CFS affected children and youth were correctly diagnosed before their 18th birthday. The mean time from disease onset to diagnosis was 6.7 years, and patients had an average of 11.1 different appointments and 2.6 misdiagnoses. A poor diagnosis rate and insufficient disease knowledge among health professionals in Switzerland led 13.5% of the patients to travel abroad to seek a diagnosis. Most patients (90.5%) were told at least once that their symptoms were psychosomatic. Swiss patients expressed high dissatisfaction with the health system and indicated that physicians lacked knowledge regarding ME/CFS. Therapies prescribed by physicians or tried by patients, as well as their perceived efficacy, were described. Graded Exercise Therapy (GET) was perceived as harmful by patients, whereas pacing, complementary/alternative medicine, and dietary supplements and medications to alleviate symptoms were reported to be helpful to varying degrees. CONCLUSION: This study highlights that poor disease knowledge among health care providers in Switzerland has led to high patient dissatisfaction, and delays in ME/CFS diagnoses and prescription of inappropriate therapies, thus adding to patient distress and disease burden.
format Online
Article
Text
id pubmed-9957780
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Taibah University
record_format MEDLINE/PubMed
spelling pubmed-99577802023-02-26 Health system support among patients with ME/CFS in Switzerland Tschopp, Rea König, Rahel S. Rejmer, Protazy Paris, Daniel H. J Taibah Univ Med Sci Original Article OBJECTIVES: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex chronic and debilitating multifactorial disease. Adequate patient care is challenged by poor knowledge among health care professionals and the historical misconception that the disease is psychological in nature. This study assessed the health-related challenges faced by patients with ME/CFS in Switzerland and examined whether they receive adequate health care. METHODS: Quantitative and qualitative data were collected through a self-administered questionnaire between June and September of 2021, among 169 patients with ME/CFS in Switzerland. RESULTS: The mean age at diagnosis was 38.8 years. Only one-third of ME/CFS affected children and youth were correctly diagnosed before their 18th birthday. The mean time from disease onset to diagnosis was 6.7 years, and patients had an average of 11.1 different appointments and 2.6 misdiagnoses. A poor diagnosis rate and insufficient disease knowledge among health professionals in Switzerland led 13.5% of the patients to travel abroad to seek a diagnosis. Most patients (90.5%) were told at least once that their symptoms were psychosomatic. Swiss patients expressed high dissatisfaction with the health system and indicated that physicians lacked knowledge regarding ME/CFS. Therapies prescribed by physicians or tried by patients, as well as their perceived efficacy, were described. Graded Exercise Therapy (GET) was perceived as harmful by patients, whereas pacing, complementary/alternative medicine, and dietary supplements and medications to alleviate symptoms were reported to be helpful to varying degrees. CONCLUSION: This study highlights that poor disease knowledge among health care providers in Switzerland has led to high patient dissatisfaction, and delays in ME/CFS diagnoses and prescription of inappropriate therapies, thus adding to patient distress and disease burden. Taibah University 2023-01-04 /pmc/articles/PMC9957780/ /pubmed/36852237 http://dx.doi.org/10.1016/j.jtumed.2022.12.019 Text en © 2023 [The Author/The Authors] https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Tschopp, Rea
König, Rahel S.
Rejmer, Protazy
Paris, Daniel H.
Health system support among patients with ME/CFS in Switzerland
title Health system support among patients with ME/CFS in Switzerland
title_full Health system support among patients with ME/CFS in Switzerland
title_fullStr Health system support among patients with ME/CFS in Switzerland
title_full_unstemmed Health system support among patients with ME/CFS in Switzerland
title_short Health system support among patients with ME/CFS in Switzerland
title_sort health system support among patients with me/cfs in switzerland
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957780/
https://www.ncbi.nlm.nih.gov/pubmed/36852237
http://dx.doi.org/10.1016/j.jtumed.2022.12.019
work_keys_str_mv AT tschopprea healthsystemsupportamongpatientswithmecfsinswitzerland
AT konigrahels healthsystemsupportamongpatientswithmecfsinswitzerland
AT rejmerprotazy healthsystemsupportamongpatientswithmecfsinswitzerland
AT parisdanielh healthsystemsupportamongpatientswithmecfsinswitzerland